A Shot in the Arm for Novartis' Pipeline
Motley Fool - 20 hours ago
On Monday, Novartis (NYSE: NVS) added to its collection a license for privately held AlphaVax's cytomegalovirus (CMV) vaccine for million, …
Novartis Buys License to AlphaVax’s Cytomegalovirus Vaccine Bloomberg
Novartis acquires license to CMV vaccine candidate The Associated Press
Alphavax, Novartis team on herpes vaccine News & Observer
BioWorld Online - SmartBrief
all 146 news articles